Yi Tian
- Biochemistry top 2%
- Immunology top 5%
- Immune Cell Function and Interaction 16
- Immunotherapy and Immune Responses 14
- T-cell and B-cell Immunology 11
- IL-33, ST2, and ILC Pathways 5
- Hepatology top 5%
- Molecular Biology top 10%
- Plant Gene Expression Analysis 8
- vaccines and immunoinformatics approaches 6
- Plant Science top 5%
- Plant Molecular Biology Research 8
-
- Cancer Immunotherapy and Biomarkers 5
- Cited by
- BiochemistryImmunologyHepatology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yi Tian
76 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 114
- Biochemistry 209
- Immunology 430
- Hepatology 139
- Molecular Biology 1.1k
- Plant Science 440
Countries citing papers authored by Yi Tian
This map shows the geographic impact of Yi Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tian more than expected).
Fields of papers citing papers by Yi Tian
This network shows the impact of papers produced by Yi Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tian. The network helps show where Yi Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 10 | |
| 13 | Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases | 2019 | 1 |
| 14 | 2019 | 34 | |
| 15 | 2017 | 18 | |
| 16 | 2016 | 83 | |
| 17 | 2015 | 7 | |
| 18 | 2014 | 30 | |
| 19 | 2014 | 7 | |
| 20 | 2013 | 68 |
About Yi Tian
Yi Tian is a scholar working on Immunology, Molecular Biology and Oncology, having authored 78 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (11 papers), Plant Gene Expression Analysis (8 papers), Plant Molecular Biology Research (8 papers), vaccines and immunoinformatics approaches (6 papers), IL-33, ST2, and ILC Pathways (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Biochemistry (209 citations), Immunology (430 citations) and Hepatology (139 citations). Yi Tian has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Bing Ni, Xiuhong An, Yu‐Jin Hao, Keqin Chen, Yuzhang Wu, Peihua Cong, Xiao‐Fei Wang, Cungang Cheng, Xiaojuan Liu and Dandan Liu. Their work appears in journals such as Frontiers in Immunology, RNA Biology, PLoS ONE, Nucleic Acids Research and International Reviews of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.